Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML

A set of myelodysplasia-related (MDS-R) gene mutations are incorporated into the 2022 European LeukemiaNet risk classification as adverse genetic factors for acute myeloid leukemia (AML) based on their poor prognostic impact on older patients. The impact of these mutations on younger patients (age &...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Xavier Cheng-Hong, Sun, Kuo-Jui, Lo, Min-Yen, Tien, Feng-Ming, Kuo, Yuan-Yeh, Tseng, Mei-Hsuan, Peng, Yen-Ling, Chuang, Yi-Kuang, Ko, Bor-Sheng, Tang, Jih-Luh, Sun, Hsun-I, Liu, Ming-Chih, Liu, Chia-Wen, Lin, Chien-Chin, Yao, Ming, Chou, Wen-Chien, Hou, Hsin-An, Tien, Hwei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813374/
https://www.ncbi.nlm.nih.gov/pubmed/36599822
http://dx.doi.org/10.1038/s41408-022-00774-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813374/
https://www.ncbi.nlm.nih.gov/pubmed/36599822
http://dx.doi.org/10.1038/s41408-022-00774-7

Ejemplares similares